Hybridoma production
Ended Awarded Last action
- Contract number
- HT942525FE003
- Awardee
-
Kemp Proteins, LLC UEI JMLEB78WL8B4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $40,000
Award facts
- Contract value 100% obligated
- $40,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Frederick, MD 21703, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $40,000 |
About this award
The Defense Health Agency awarded a $40,000 firm fixed-price delivery order to Kemp Proteins, LLC (doing business as Kempbio) on August 1, 2025, for hybridoma production services. The contract, designated as a Total Small Business set-aside, is scheduled for completion by July 31, 2026, and will be performed at the contractor's facility in Frederick, Maryland. Kempbio is a small disadvantaged business specializing in gene-to-protein bioservices and biological research support, with established experience delivering immunological materials and laboratory services across multiple federal agencies including the National Institute of Allergy and Infectious Diseases, the Food and Drug Administration, and the National Institute of Dental and Craniofacial Research.
This delivery order leverages Kempbio's core competencies in monoclonal antibody and hybridoma production, areas in which the contractor has demonstrated consistent federal performance. The company's cumulative documented prime contract value exceeds $300,000, and it maintains a significant $10 million Blanket Purchase Agreement with the Office of Logistics and Acquisition Operations through August 2026, which facilitates recurring procurement of biological materials and laboratory services. The hybridoma production capability supports the Defense Health Agency's biomedical research and vaccine development objectives within the Department of Defense health portfolio.
Quick answers
Who was awarded contract HT942525FE003?
HT942525FE003 was awarded to Kemp Proteins, LLC by Defense Health Agency (Department of Defense) on August 1, 2025.
How much is contract HT942525FE003 worth?
The government has obligated $40,000 on HT942525FE003.
Is contract HT942525FE003 an order under another contract?
Yes. HT942525FE003 is a delivery order under HT942525D0002, an indefinite delivery contract.
Was contract HT942525FE003 competed?
The extent of competition for HT942525FE003 was competed under sap. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award